Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
Active, not recruiting · NCT04340596 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 1 | 2026-08-26 | NCT04340596 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ImmunityBio, Inc. | 28 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
| Rockefeller University | 21 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alabama CRS (Site ID# 31788) | Birmingham | United States | 1 |
| Chapel Hill CRS (Site ID: 3201) | Chapel Hill | United States | 1 |
| Columbia P&S CRS | New York | United States | 4 |
| Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101) | Boston | United States | 1 |
| New Jersey Medical School Clinical Research Center CRS [Site ID: 31786] | Newark | United States | 1 |
| Northwestern University CRS | Chicago | United States | 2 |
| Penn Therapeutics, CRS (Site ID: 6201) | Philadelphia | United States | 1 |
| UCLA CARE Center CRS | Los Angeles | United States | 1 |
| UCSD Antiviral Research Center CRS (Site ID: 701) | San Diego | United States | 1 |
| University of California, San Fransisco HIV/AIDS CRS | San Francisco | United States | 1 |
| Washington University Therapeutics (WT) CRS | St Louis | United States | 1 |
| Weill Cornell Uptown CRS (Site ID: 7803) | New York | United States | 1 |
| Whitman-Walker Institute, Inc. CRS (Site ID: 31791) | Washington D.C. | United States | 1 |